{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:01:06Z","timestamp":1772067666092,"version":"3.50.1"},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,26]]},"DOI":"10.18632\/oncotarget.10296","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T15:07:13Z","timestamp":1466867233000},"page":"47938-47953","source":"Crossref","is-referenced-by-count":30,"title":["EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway"],"prefix":"10.18632","volume":"7","author":[{"given":"Xiuxiu","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Maternal and Child Health, School of Public Health, Shandong University, Jinan, 250012, China"},{"name":"The No.1 People's Hospital of Jining, Jining 272000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Fang","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology, Georgetown University, Georgetown, Washington D.C, 20057, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Shandong Provincial Hospital affiliated to Shandong University, Jinan, 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, the Second Hospital affiliated to Jilin University, Jilin, 130000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Fang","sequence":"additional","affiliation":[{"name":"Clinical Medicine, School of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, School of Public Health, Shandong University, Jinan, 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Ward","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"2","first-page":"365867","article-title":"Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line","author":"Zabel","year":"2014","journal-title":"Biomed Res Int"},{"key":"3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Shih Ie","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Mills","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Weinberg","year":"2011","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00018-009-8632-6","article-title":"Fibulins: multiple roles in matrix structures and tissue functions","volume":"66","author":"Yamada","year":"2009","journal-title":"Cell Mol Life"},{"key":"7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.acc.2014.09.008","article-title":"Fibulins and their role in cardiovascular biology and disease","volume":"67","author":"Rasmussen","year":"2014","journal-title":"Adv Clin Chem"},{"key":"8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.molmed.2005.06.001","article-title":"Fibulins and cancer: friend or foe?","volume":"11","author":"Whelan","year":"2005","journal-title":"Trends Mol Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2010.11.004","article-title":"EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer","volume":"121","author":"Kong","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1541-7786.MCR-08-0132","article-title":"EFEMP1 expression promotestumor growth in human pancreatic adenocarcinoma","volume":"7","author":"Thieme","year":"2009","journal-title":"Mol Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1158\/1541-7786.MCR-09-0207","article-title":"Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion","volume":"7","author":"Viapiano","year":"2009","journal-title":"Mol Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/ijc.24108","article-title":"Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker","volume":"124","author":"Betz","year":"2009","journal-title":"Int J Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.2776","article-title":"Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity","volume":"222","author":"Fang","year":"2010","journal-title":"J Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-4598-10-123","article-title":"EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment","volume":"10","author":"Chaturbedi","year":"2011","journal-title":"Mol Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"e78783","DOI":"10.1371\/journal.pone.0078783","article-title":"Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"Plos One"},{"key":"16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2012.06.019","article-title":"The dual role of fibulins in tumorigenesis","volume":"325","author":"Cal","year":"2012","journal-title":"Cancer Lett"},{"key":"17","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1074\/jbc.M114.582239","article-title":"p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion","volume":"290","author":"Porras","year":"2015","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-14-0685","article-title":"Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas","volume":"74","author":"Viapiano","year":"2014","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/0008-5472.CAN-12-1060","article-title":"Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling","volume":"72","author":"Viapiano","year":"2012","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/carcin\/bgu023","article-title":"Fibulin-3 suppresses Wnt\/\u03b2-catenin signaling and lung cancer invasion","volume":"35","author":"Zhang","year":"2014","journal-title":"Carcinogenesis"},{"key":"21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3892\/or_00000304","article-title":"Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma","volume":"21","author":"Li","year":"2009","journal-title":"Oncol Rep"},{"key":"22","article-title":"AKT signaling in ERBB2-amplified breast cancer","author":"Scaltriti","year":"2015","journal-title":"Pharmacol Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/onc.2013.373","article-title":"Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling","volume":"33","author":"Cho","year":"2014","journal-title":"Oncogene"},{"key":"24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1515\/BC.2009.140","article-title":"EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells","volume":"390","author":"Bruns","year":"2009","journal-title":"Biol Chem"},{"key":"25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2001-1326-3-17","article-title":"Clinical significance of epithelial-mesenchymal transition","volume":"3","author":"Steinestel","year":"2014","journal-title":"Clin Transl Med"},{"key":"26","first-page":"e28975","article-title":"STAT3 and epithelial-mesenchymal transitions in carcinomas","volume":"3","author":"Schiemann","year":"2014","journal-title":"JAKSTAT"},{"key":"27","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Settleman","year":"2010","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00432-008-0526-8","article-title":"Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones","volume":"135","author":"Fu","year":"2009","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T04:57:01Z","timestamp":1656737821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,25]]},"references-count":28,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016,7,26]]}},"alternative-id":["10296","27351229"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10296","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,25]]}}}